Insider Trading - Bahrt Kenneth
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-12-22 Sale | 2017-12-26 5:06 pm | Oncobiologics Inc. | ONS | Bahrt Kenneth Chief Medical Officer | 26,165 | $1.13 | $29,566 | 54,820 (Direct) | View |
| 2018-06-25 Sale | 2018-06-27 7:52 pm | Oncobiologics Inc. | ONS | Bahrt Kenneth Chief Medical Officer | 7,700 | $0.8451 | $6,507 | 47,120 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-12-21 Option Award | 2016-12-22 6:00 pm | N/A N/A | Oncobiologics Inc. | ONS | Bahrt Kenneth Chief Medical Officer | 50,000 | $0 | 80,985 (Direct) | View |
| 2018-10-22 Option Award | 2018-10-24 5:03 pm | N/A 2028-10-22 | Oncobiologics Inc. | ONS | Bahrt Kenneth Chief Medical Officer | 450,000 | $0 | 450,000 (Direct) | View |
| 2019-02-19 Option Award | 2019-02-19 8:23 pm | N/A 2029-02-19 | Outlook Therapeutics Inc. | OTLK | Bahrt Kenneth Chief Medical Officer | 600,000 | $0 | 600,000 (Direct) | View |